NCT04323410 Casting Versus Percutaneus Pinning Treatment of Pediatric Overriding Distal Forearm Fractures
| NCT ID | NCT04323410 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Töölö Hospital |
| Condition | Pediatric Overriding Distal Metaphyseal Radius Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2020-06-29 |
| Primary Completion | 2025-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2020-06-29 with a primary completion date of 2025-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized controlled trial comparing casting in finger-trap traction without reduction versus closed reduction and percutaneous pin fixation of dorsally displaced, overriding distal metaphyseal radius fractures in under eleven years old children.
Eligibility Criteria
Inclusion Criteria: * Child with open epiphysis with closed overriding metaphyseal distal radial fracture with or without an associated fracture of the ulna * Normal communication development (languages Finnish, Swedish, English) Exclusion Criteria: * Bilateral forearm injuries * Gustillo-Anderson grade II or III open fracture * Galeazzi fracture-dislocation * Polytrauma * Neurovascular injury of the ipsilateral upper extremity * History of a displaced forearm fracture * Underlying disease affecting fracture healing
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04323410 clinical trial?
This trial is open to participants of all sexes, up to 10 Years, studying Pediatric Overriding Distal Metaphyseal Radius Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04323410 currently recruiting?
Yes, NCT04323410 is actively recruiting participants. Contact the research team at topi.laaksonen@hus.fi for enrollment information.
Where is the NCT04323410 trial being conducted?
This trial is being conducted at Helsinki, Finland.
Who is sponsoring the NCT04323410 clinical trial?
NCT04323410 is sponsored by Töölö Hospital. The trial plans to enroll 60 participants.